foot
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
C h a p t e r 8<br />
Performance Enhancing Drugs<br />
increased availability of newer AAS, the 2004 Anabolic Steroid Control Act was<br />
passed and this increased the number of AAS that were considered Schedule III drugs<br />
and tightened the definition of AAS. Included in the 2004 Act were THG and norbolethone,<br />
as well as many former dietary supplements that include androstenedione,<br />
androstenediol and 19-norandrostenedione. As of this time, DHEA is still considered<br />
to be a dietary supplement and can be sold over-the-counter.<br />
While there is no debate on the fact that large doses of AAS can increase muscle<br />
mass, the effects on actual performance are less clear. In many sports, performance is<br />
difficult to measure as it is influenced by factors other than strength alone. Despite<br />
the widespread use of anabolic steroids in athletes, there is little data to support its<br />
effects on performance. Studies have been limited to obvious targets such as weight<br />
lifting and measuring acceleration in sprinters. In addition to strength changes, there<br />
are additional AAS effects that may contribute to efficacy in athletes. Many have<br />
attributed AAS strength gains to increases in aggressiveness that encourages intensity<br />
in both training and competition. Although there are AAS receptors in brain tissue,<br />
it is unclear as to their role. Regardless of the actual mechanism, it is clear that athletes<br />
believe that AAS improve performance and have continued to use them.<br />
Any discussion of the adverse effects associated with AAS are complicated by the fact<br />
that scientific studies use doses of AAS far below what has been reported by athletes.<br />
As a result, it is likely that medical studies underestimate the full extent of side effects<br />
from AAS use. These studies do not begin to approximate the doses used by athletes<br />
that may be 10-40 times the therapeutic dose and in multiple combinations. AAS<br />
affect virtually every organ in the body and their effects can be divided into organ<br />
system effects, psychological effects, sex-specific effects and potential effects on immature<br />
individuals.<br />
The two systems that have been most studied are the cardiovascular and gastrointestinal<br />
systems. AAS affect the cardiovascular system by increasing total cholesterol,<br />
LDL (bad) cholesterol and blood pressure, while lowering HDL (good) cholesterol.<br />
When these are combined with the potential clotting effects of AAS, the risk of coronary<br />
artery disease dramatically increases and the possibility of heart attacks. Indeed,<br />
there are multiple reports of relatively young AAS users suffering heart attacks. There<br />
have also been reports of AAS-induced cardiomyopathy (heart enlargement) following<br />
continued use of very high doses of these drugs.<br />
225